Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


mHealth Innovators Seek Access To More Wireless Spectrum

This article was originally published in The Gray Sheet

Executive Summary

Mobile health innovators want federal policy makers to speed up plans to allocate additional wireless spectrum for use in the mobile health space.

You may also be interested in...

FCC Moves Ahead On Strategy To Foster Innovation In Wireless Health Technologies

FCC Chairman Julius Genachowski thinks making changes to spectrum policy could free up new uses for wireless health technologies.

Industry Applauds FDA Draft Guidance On Mobile Medical Apps

The medical device and software industries voiced support last week for a July 19 FDA draft guidance that helps clarify the types of mobile software applications that would face FDA regulation.

Industry Meets With FDA On Mobile Health Regulatory Plan

Members of the mHealth Regulatory Coalition hope their recent closed-door meeting with FDA will help lay the groundwork for clarifying which mobile health devices and software applications will face agency oversight.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts